Maureen Dubreuil MD, MSc.
Associate Professor, Rheumatology
650 Albany St | (617) 638-5180maureen.dubreuil@bmc.org
mdubreui@bu.edu
Sections
Rheumatology
Centers
Arthritis & Autoimmune Diseases Research Center
Biography
Dr. Dubreuil is a rheumatologist in Boston, specializing in spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. Dr. Dubreuil's research has been funded by numerous competitive grants from funders including the NIH, private foundations and industry. Some highlights of Dr. Dubreuil's work includes:
1. Discovery of two key protective effects of TNF inhibitors against fractures and cardiovascular events in spondyloarthritis
2. Finding that a common nonsteroidal anti-inflammatory drug is associated with 3 times the risk of heart attack among people with spondyloarthritis
3. Development of the first North American guidelines for referral of adults at increased risk of having spondyloarthritis to a rheumatologist
In addition to her research, Dr. Dubreuil is a member of the leading international organizations for spondyloarthritis research. She serves on the Executive Committee of the Board of Directors for the Spondyloarthritis Research and Treatment Network, and on the Medical Advisory Board for the Spondylitis Association of America. She is a site investigator for the international CLASSIC study in spondyloarthritis. Dr. Dubreuil is the Director of Research Training for the Rheumatology Fellowship program at Boston Medical Center.
Dr. Dubreuil cares for people with rheumatic conditions at Boston Medical Center and the VA Boston Healthcare System. Dr. Dubreuil's patients say the following about her:
"Dr. Dubreuil is a very caring and knowledgeable doctor and it's always a pleasure to be seen by her."
"I am very satisfied with the care I have received. My provider and the support staff is very professional, caring and concerned. I would recommend to anyone."
"Dr. Dubreuil is a gem and I feel so lucky to have her!"
Websites
Dr. Dubreuil's publications on PubMed
Dr. Dubreuil's profile on LinkedIn
Rheumatology Faculty at BU Medical Center
BU Musculoskeletal Clinical Research Collaboratory
American College of Rheumatology Abstracts by Dr. Dubreuil
ACR On Air Podcast Episode: Treating Spondyloarthritis
BU Rheumatology Fellowship Program Video
An interview on WebMD about Ankylosing Spondylitis
SPARTAN (Spondyloarthritis Research and Treatment Network)
Education
Medicine-Internal, MD, University of Connecticut School of Medicine
MSc, Boston University School of Public Health
Biology, BS, Rochester Institute of Technology
Publications
Ferrandiz-Espadin R, Rabasa G, Gasman S, McGinley B, Stovall R, Jafarzadeh SR, Liew JW, Dubreuil M. Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis. J Rheumatol. 2025 Apr 01; 52(4):344-351. PMID: 39486857.
Published on 3/16/2025Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Association of Physical Therapy Care With Use of Intra-Articular Injections in People With Knee Osteoarthritis: A Real-World Cohort Study. Arthritis Rheumatol. 2025 Mar 16. PMID: 40091450.
Published on 3/15/2025Choufani M, Ghusn W, Dubreuil M, Ermann J. Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region. J Rheumatol. 2025 Mar 15. PMID: 40089303.
Published on 3/1/2025Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi T, Pillinger MH, Riggs KR, Saag KG, Shekelle PG, Tseng Z, Toprover M, Wei DS, Barry MJ, Choi HK. The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. ACR Open Rheumatol. 2025 Mar; 7(3):e70012. PMID: 40126890.
Published on 2/12/2025Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Hughes GC, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2025 Feb 12. PMID: 39936579.
Published on 2/1/2025Jinno S, Onishi A, Hattori S, Dubreuil M, Ueda Y, Nishimura K, Okano T, Yamada H, Yamamoto W, Murata K, Onizawa H, Ebina K, Maeda Y, Son Y, Amuro H, Hara R, Hata K, Shiba H, Katayama M, Watanabe R, Hashimoto M, Saegusa J. Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study. Rheumatology (Oxford). 2025 Feb 01; 64(2):509-516. PMID: 38317442.
Published on 1/1/2025Navarro-Compán V, Rudwaleit M, Dubreuil M, Magrey M, Marzo-Ortega H, Mease PJ, Walsh JA, Dougados M, de la Loge C, Fleurinck C, Massow U, Vaux T, Taieb V, Deodhar A. Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies. J Rheumatol. 2025 Jan 01; 52(1):23-32. PMID: 39406403.
Published on 12/16/2024Driscoll D, George N, Peloquin C, Jafarzadeh SR, Liew JW, Dubreuil M. Association of Therapies for Axial Spondyloarthritis on the Risk of Hip and Spine Fractures. Arthritis Rheumatol. 2024 Dec 16. PMID: 39679763.
Published on 12/1/2024Dubreuil M, Ferucci ED, El-Gabalawy H, Hasni S, Williams EM. Enhancing Equity in Clinical Research: A Multifaceted Proposal for Spondyloarthritis. J Rheumatol. 2024 Dec 01; 51(12):1247-1253. PMID: 39448246.
Published on 12/1/2024Colbert RA, Carroll E, Dubreuil M, Gensler LS, Haroon N, Howard R, Ogdie AR, Shafer C, Weiss PF, Kuhn KA. Prologue: Spondyloarthritis Unmet Research Needs Conference IV. J Rheumatol. 2024 Dec 01; 51(12):1226-1228. PMID: 39448249.
Media Mentions
Published on 11/15/2023
First Referral Guide Issued for Axial Spondyloarthritis
Published on 6/16/2022
The Consumer’s Guide to JAK Inhibitors for Ankylosing Spondylitis
Published on 2/15/2022
How to Tell Psoriatic Arthritis vs. Rheumatoid Arthritis Apart
Published on 12/21/2021
How medicine erased Black women from a ‘white man’s disease’
Published on 11/19/2018
Case Report: Acne Drug Leads Patient to Retinoid Hyperostosis
View full list of 5 media mentions.